Has Ryan Wakim received payments from drug or device companies?

Yes. Drug and device makers reported $771,682 in general payments to Ryan Wakim across 961 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Wakim did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Wakim come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Wakim

Psychiatry · Wheeling, WVNPI 1093033789

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $514,145 of the $771,682 with a category attached, or 66.6%. 20 manufacturers reported payments, led by Johnson & Johnson at 44.7% of the total. Among psychiatry clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$771,682in general payments, 2019–2025

Across 961 payments — averaging $803.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$345K
Axsome Therapeutics, Inc.$294K
AbbVie$111K
Neuronetics, Inc.$11K
Alkermes, Inc.$7K
Teladoc Health, Inc.$3K
plus $834 from 14 others

What the payments were for

Consulting fees$144,30919%
Speaking & faculty fees$514,14567%
Travel & lodging$93,94412%
Food & beverage$19,2842%
Education$10%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	440	$344,886
Axsome Therapeutics, Inc.	287	$293,588
AbbVie	105	$111,453
Neuronetics, Inc.	79	$11,350
Alkermes, Inc.	11	$6,971
Teladoc Health, Inc.	3	$2,600
Neurocrine Biosciences, Inc.	4	$248
Sunovion Pharmaceuticals Inc.	8	$143
Takeda Pharmaceuticals U.S.A., Inc.	5	$75
Indivior Inc.	4	$71
Vanda Pharmaceuticals Inc.	2	$55
Neos Therapeutics, LP	2	$39
Otsuka America Pharmaceutical, Inc.	2	$39
Lundbeck LLC	2	$38
Brainsway USA Inc	2	$34
Janssen Scientific Affairs, LLC	1	$31
MDD US Operations, LLC	1	$20
Biogen	1	$15
Shire North American Group Inc	1	$15
Alfasigma USA, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$771,682 in reported general payments places this provider in the 95th percentile of 177 psychiatry providers in West Virginia.

See all psychiatry providers in West Virginia →

Other psychiatry in Wheeling

Steve CorderWheeling$57K
Alfredo AguirreWheeling$2K
Paul PapadimitriouWheeling$832
Melissa MoodyCharleston$1.2M
April BaisdenScott Depot$775K
Daniel ThistlethwaiteSouth Charleston$468K
Walter ByrdMorgantown$299K
Fahd MousaCharleston$200K
Debra StultzBarboursville$173K
Shahnoor KhanMartinsburg$161K

See the full list for West Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →